111, Inc. (YI)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 05, 2025

$6.22

P/E Ratio

N/A

Market Cap

$59.79M

Description
Add to research

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

Metrics
Add to research

Overview

  • HQShanghai, SH
  • SectorDistribution Services
  • IndustryMedical Distributors
  • TickerYI
  • Price$6.22-4.01%

Trading Information

  • Market cap$59.79M
  • Float98.55%
  • Average Daily Volume (1m)227,857
  • Average Daily Volume (3m)233,750
  • EPS-$4.15

Company

  • Revenue$2.03B
  • Rev growth (1yr)-0.68%
  • Net income-$2.39M
  • Gross margin5.85%
  • EBITDA marginN/A
  • EBITDAN/A
  • EV$144.12M
  • EV/Revenue0.07
  • P/EN/A
  • P/S0.03
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research